Table of Contents
ISRN Urology
Volume 2011 (2011), Article ID 605436, 5 pages
http://dx.doi.org/10.5402/2011/605436
Research Article

Iron Inhibits Respiratory Burst of Peritoneal Phagocytes In Vitro

1Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Cracow, Poland
2Molecular Neuropharmacology Group, Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, Building 18.6, 2200 Copenhagen N, Denmark
3Department of Nephrology and Dialysis, Rydygier Hospital, Złota Jesień 1, 31-826 Cracow, Poland

Received 15 August 2011; Accepted 15 September 2011

Academic Editors: J. R. Drevet, A. M. El-Assmy, and F. M. Wagenlehner

Copyright © 2011 Kamil Gotfryd et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Valderrâbano, “Erythropoietin in chronic renal failure,” Kidney International, vol. 50, no. 4, pp. 1373–1391, 1996. View at Google Scholar
  2. I. C. Macdougall, G. Chandler, O. Elston, and J. Harchowal, “Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit,” American Journal of Kidney Diseases, vol. 34, no. 4, supplement 2, pp. S40–S46, 1999. View at Google Scholar · View at Scopus
  3. J. Eschbach, P. DeOreo, J. Adamson et al., “NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure,” American Journal of Kidney Diseases, vol. 30, supplement 3, pp. S192–S240, 1997. View at Google Scholar
  4. G. J. Anderson, “Mechanisms of iron loading and toxicity,” American Journal of Hematology, vol. 82, no. 12, pp. 1128–1131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Walker Jr. and S. M. Walker, “Eeffects of iron overload on the immune system,” Annals of Clinical and Laboratory Science, vol. 30, no. 4, pp. 354–365, 2000. View at Google Scholar · View at Scopus
  6. N. R. Powe, B. Jaar, S. L. Furth, J. Hermann, and W. Briggs, “Septicemia in dialysis patients: incidence, risk factors, and prognosis,” Kidney International, vol. 55, no. 3, pp. 1081–1090, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. H. J. Forman and M. Torres, “Signaling by the respiratory burst in macrophages,” IUBMB Life, vol. 51, no. 6, pp. 365–371, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Davenport, “Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003,” Peritoneal Dialysis International, vol. 29, no. 3, pp. 297–302, 2009. View at Google Scholar · View at Scopus
  9. J. C. Chow, D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky, “Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction,” Journal of Biological Chemistry, vol. 274, no. 16, pp. 10689–10692, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. G. R. Aronoff, W. M. Bennett, S. Blumenthal et al., “Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens,” Kidney International, vol. 66, no. 3, pp. 1193–1198, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Furuland, T. Linde, J. Ahlmén, A. Christensson, U. Strömbom, and B. G. Danielson, “A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients,” Nephrology Dialysis Transplantation, vol. 18, no. 2, pp. 353–361, 2003. View at Publisher · View at Google Scholar
  12. M. E. Canziani, S. T. Yumiya, E. B. Rangel, S. R. Manfredi, M. C. Neto, and S. A. Draibe, “Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment,” Artificial Organs, vol. 25, no. 11, pp. 866–869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. C. May and W. E. Mitch, “Pathophysiology of uremia,” in The Kidney, B. M. Brenner and F. C. Rector, Eds., W. B. Saunders, Philadelphia, Pa, USA, 1996. View at Google Scholar
  14. M. P. Kooistra and J. J. M. Marx, “The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients,” Nephrology Dialysis Transplantation, vol. 13, no. 10, pp. 2578–2582, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Daniels, K. S. Bhatia, C. J. Porter et al., “Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent,” Clinical and Diagnostic Laboratory Immunology, vol. 3, no. 6, pp. 682–688, 1996. View at Google Scholar · View at Scopus
  16. J. Wilhelm, A. Skoumalová, R. Vytášek, B. Fišárková, P. Hitka, and L. Vajner, “Erythrocyte membranes inhibit respiratory burst and protein nitration during phagocytosis by macrophages,” Physiological Research, vol. 54, no. 5, pp. 533–539, 2005. View at Google Scholar